52Repeat authorisations

52 Repeat authorisations

(1) This section does not apply in relation to the supply of a pharmaceutical benefit on the basis of a medication chart prescription. Circumstances of supply (2) Subsection (3) applies if: (a) an approved pharmacist, an approved medical practitioner or an approved hospital authority supplies a pharmaceutical benefit under: (i) a Medicare/DVA copy of a paper‑based prescription that contains a direction to supply the benefit more than once; or (ii) a pharmacist/patient copy of a paper‑based prescription to which is attached a deferred supply authorisation that contains a direction to supply the benefit more than once; or (iii) a pharmacist/patient copy of a paper‑based prescription to which is attached a repeat authorisation that contains a direction to supply the benefit more than once; or (iv) an electronic prescription that contains a direction to supply the benefit more than once; or (v) an electronic prescription to which is attached or linked, by electronic means, a deferred supply authorisation that contains a direction to supply the benefit more than once; or (vi) an electronic prescription to which is attached or linked, by electronic means, a repeat authorisation that contains a direction to supply the benefit more than once; and (b) subsequent supplies of the pharmaceutical benefit can be made under the prescription at the time of supply under paragraph (a). Requirement to prepare repeat authorisation (3) The approved pharmacist, approved medical practitioner or approved hospital authority must: (a) on or before supplying the pharmaceutical benefit: (i) prepare a repeat authorisation in accordance with a form (including a paper‑based or an electronic form) approved, in writing, by the Secretary for the supply of the pharmaceutical benefit; and (ii) if the prescription for the pharmaceutical benefit is written on an authority prescription—mark the number of the authority prescription on the repeat authorisation; and (iii) if the prescription for the pharmaceutical benefit is a paper‑based prescription—attach the repeat authorisation to the pharmacist/patient copy and give the repeat authorisation and pharmacist/patient copy to the person to whom the pharmaceutical benefit is supplied; and (iv) if the prescription for the pharmaceutical benefit is an electronic prescription—attach or link, by electronic means, the repeat authorisation to the electronic prescription and ensure that the person to whom the pharmaceutical benefit is supplied is given a print‑out of the repeat authorisation and prescription or is able to access the repeat authorisation and prescription; and (b) for the supply of the pharmaceutical benefit on the first occasion—mark on the repeat authorisation: (i) the name and address of the approved supplier; and (ii) the approval number given to the approved supplier under section 16; and (iii) the identifying number given to the prescription by the approved supplier; and (iv) if the pharmaceutical benefit is a substitute benefit for the purposes of subsection 103(2A) of the Act—the brand name of the substitute benefit; and (c) for the supply of the pharmaceutical benefit on a subsequent occasion—mark on the repeat authorisation: (i) the date on which the most recent supply was made; and (ii) the identifying number given to the prescription under subparagraph (b)(iii). (4) An approved pharmacist, approved medical practitioner or approved hospital authority commits an offence if the pharmacist, medical practitioner or hospital authority (as the case may be) contravenes subsection (3).